Medicina
Facultad
Institute of Clinical and Experimental Medicine
Praga, República ChecaPublicacións en colaboración con investigadores/as de Institute of Clinical and Experimental Medicine (47)
2023
-
Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium
Molecular Psychiatry, Vol. 28, Núm. 3, pp. 1201-1209
-
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 14
-
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
Europace, Vol. 25, Núm. 4, pp. 1284-1295
2022
-
An exome-wide study of renal operational tolerance
Frontiers in Medicine, Vol. 9
-
Class II HLA in Georgia Caucasus Tbilisi Georgians and their Mediterranean ancestry: The Usko Mediterranean languages
Human Immunology, Vol. 83, Núm. 11, pp. 739-740
-
Natural History of MYH7-Related Dilated Cardiomyopathy
Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461
2021
-
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
eLife, Vol. 10
-
Long-term risks after kidney donation: How do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groups
Nephrology Dialysis Transplantation, Vol. 36, Núm. 9, pp. 1742-1753
-
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy
Journal of the American Society of Nephrology, Vol. 32, Núm. 2
2020
-
Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy
EBioMedicine, Vol. 58
-
Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction—Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial
American Heart Journal, Vol. 224, pp. 129-137
-
Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA
NeuroImage, Vol. 218
-
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22
-
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
Cardiac Failure Review, Vol. 6
2019
-
Rising rural body-mass index is the main driver of the global obesity epidemic in adults
Nature
-
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study
Transplantation, Vol. 103, Núm. 9, pp. 1953-1963
-
Standard work-up of the low-risk kidney transplant candidate: A European expert survey of the ERA-EDTA Developing Education Science and Care for Renal Transplantation in European States Working Group
Nephrology Dialysis Transplantation, Vol. 34, Núm. 9, pp. 1605-1611
2018
-
Establishing the European diagnostic reference levels for interventional cardiology
Physica Medica, Vol. 54, pp. 42-48
2017
-
Long-term risks of kidney living donation: Review and position paper by the ERA-EDTA DESCARTES working group
Nephrology Dialysis Transplantation, Vol. 32, Núm. 2, pp. 216-223